Underuse of Prevention and Lifestyle Counseling in Patients With Peripheral Artery Disease

Journal of the American College of Cardiology

Volumn 69, Issue 18, 2017, Pages 2293-2300

  Berger, Jeffrey S ^a   Ladapo, Joseph A ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cardiovascular prevention; epidemiology; lifestyle; PAD

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; CILOSTAZOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AFRICAN AMERICAN; AGE; AGED; ARTICLE; CLAUDICATION; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; EUROPEAN AMERICAN; EXERCISE; FEMALE; HISPANIC; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PATIENT COUNSELING; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRACTICE GUIDELINE; SMOKING CESSATION; TREND STUDY; UNITED STATES; AMBULATORY CARE; DIRECTIVE COUNSELING; ETHNOLOGY; LIFESTYLE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; RISK REDUCTION; SECONDARY PREVENTION; STATISTICS AND NUMERICAL DATA; UTILIZATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; DIRECTIVE COUNSELING; FEMALE; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; OFFICE VISITS; PERIPHERAL ARTERIAL DISEASE; RISK REDUCTION BEHAVIOR; SECONDARY PREVENTION;

EID: 85018445836     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2017.02.064     Document Type: Article

References (22)

1. 1 Fowkes, F.G., Rudan, D., Rudan, I., et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 382 (2013), 1329–1340.
2. 2 Savji, N., Rockman, C.B., Skolnick, A.H., et al. Association between advanced age and vascular disease in different arterial territories: a population database of over 3.6 million subjects. J Am Coll Cardiol 61 (2013), 1736–1743.
3. 3 Mozaffarian, D., Benjamin, E.J., Go, A.S., et al. Heart disease and stroke statistics–2016 update: a report from the American Heart Association. Circulation 133 (2016), e38–e360.
4. 4 Criqui, M.H., Aboyans, V., Epidemiology of peripheral artery disease. Circ Res 116 (2015), 1509–1526.
5. 5 Subherwal, S., Patel, M.R., Kober, L., et al. Peripheral artery disease is a coronary heart disease risk equivalent among both men and women: results from a nationwide study. Eur J Prev Cardiol 22 (2015), 317–325.
6. 6 Gerhard-Herman, M.D., Gornik, H.L., Barrett, C., et al. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 69 (2017), e71–e126.
7. 7 Berger, J.S., Hiatt, W.R., Medical therapy in peripheral artery disease. Circulation 126 (2012), 491–500.
8. 8 Hivert, M.F., Arena, R., Forman, D.E., et al. Medical training to achieve competency in lifestyle counseling: an essential foundation for prevention and treatment of cardiovascular diseases and other chronic medical conditions: a scientific statement from the American Heart Association. Circulation 134 (2016), e308–e327.
9. 9 Cacoub, P.P., Abola, M.T., Baumgartner, I., et al. Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) registry. Atherosclerosis 204 (2009), e86–e92.
10. 10 Pande, R.L., Perlstein, T.S., Beckman, J.A., Creager, M.A., Secondary prevention and mortality in peripheral artery disease: National Health and Nutrition Examination Study, 1999 to 2004. Circulation 124 (2011), 17–23.
11. 11 Subherwal, S., Patel, M.R., Kober, L., et al. Missed opportunities despite improvement in use of cardioprotective medications among patients with lower-extremity peripheral artery disease, underuse remains. Circulation 126 (2012), 1345–1354.
12. 12 Cacoub, P.P., Zeymer, U., Limbourg, T., et al. Effects of adherence to guidelines for the control of major cardiovascular risk factors on outcomes in the REduction of Atherothrombosis for Continued Health (REACH) Registry Europe. Heart 97 (2011), 660–667.
13. 13 National Center for Health Statistics (U.S.). Ambulatory Health Care Data: NAMCS and NHAMCS Description. 2013. Available at: http://www.cdc.gov/nchs/ahcd/ahcd_questionnaires.htm. Accessed June 4, 2013.
14. 14 National Center for Health Statistics (U.S.). 2009 NAMCS Public-Use Data File Documentation. Available at: http://www.cdc.gov/nchs/ahcd/ahcd_questionnaires.htm. Accessed June 4, 2013.
15. 15 Hirsch, A.T., Allison, M.A., Gomes, A.S., et al. A call to action: women and peripheral artery disease: a scientific statement from the American Heart Association. Circulation 125 (2012), 1449–1472.
16. 16 Ladapo, J.A., Blecker, S., Douglas, P.S., Physician decision making and trends in the use of cardiac stress testing in the United States: an analysis of repeated cross-sectional data. Ann Intern Med 161 (2014), 482–490.
17. 17 Sigmund, A.E., Stevens, E.R., Blitz, J.D., Ladapo, J.A., Use of preoperative testing and physicians' response to professional society guidance. JAMA Intern Med 175 (2015), 1352–1359.
18. 18 National Center for Health Statistics (U.S.). Ambulatory Health Care Data: NAMCS and NHAMCS, Reliability of Estimates. 2013. Available at: http://www.cdc.gov/nchs/ahcd/ahcd_estimation_reliability.htm. Accessed June 4, 2013.
19. 19 Donohoe, M.T., Comparing generalist and specialty care: discrepancies, deficiencies, and excesses. Arch Intern Med 158 (1998), 1596–1608.
20. 20 Cebul, R.D., Love, T.E., Jain, A.K., Hebert, C.J., Electronic health records and quality of diabetes care. N Engl J Med 365 (2011), 825–833.
21. 21 Jepson, R.G., Harris, F.M., Platt, S., Tannahill, C., The effectiveness of interventions to change six health behaviours: a review of reviews. BMC Public Health, 10, 2010, 538.
22. 22 Armstrong, E.J., Chen, D.C., Westin, G.G., et al. Adherence to guideline-recommended therapy is associated with decreased major adverse cardiovascular events and major adverse limb events among patients with peripheral arterial disease. J Am Heart Assoc, 3, 2014, e000697.